Found 7 matching trials
Vaccine Therapy With or Without Recombinant Interleukin-12 Followed by Daclizumab in Treating Patients With Metastatic Melanoma
PHASE2This randomized phase II trial is studying how well giving vaccine therapy ...
Location
University of Chicago Comprehensive Cancer Center
Peptide Vaccinations Plus GM-CT-01 in Melanoma
PHASE1The purpose of this study is to determine whether the intravenous and/or GM...
Location
Cliniques Universitaires Saint Luc
Immunization With 8 Peptides Mixed With CpG 7909 or Montanide ISA51 in Patients With Metastatic Cutaneous Melanoma
PHASE1The purposes of this study are to describe the immune response to individua...
Location
Clinique Universitaires St-Luc
Peptide Vaccination Associated With Tumoral Immunomodulation in Patients With Advanced Metastatic Melanoma
PHASE1Human cancers express tumor antigens that can be targeted by cytolytic T ly...
Location
Cliniques Universitaires Saint-Luc
Immunization of Disease-Free Melanoma Patients With Different HLA-A2 Peptides
PHASE1Open-label single center study. Patients will be divided in four groups of ...
Location
Cliniques Universitaires Saint-Luc
Vaccine Therapy in Treating Patients With Melanoma of the Eye
PHASE3RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Location
Cliniques Universitaires Saint-Luc
Immunotherapy of HLA-A2 Positive Stage II-IV Melanoma Patients
PHASE1The purpose of this study is to determine whether vaccination with tumor an...
Location
Oncology Department, CHUV